Evaxion and the European Investment Bank (EIB) have finalized a debt settlement agreement of €3.5 million out of Evaxion’s €7 million loan with EIB, to be used for EIB to purchase €3.5 million worth of ordinary Evaxion warrantsEIB will purchase the warrants at a price of $4.87 corresponding to a premium of 89% to the share price by market close yesterday The agreement immediately increases Evaxion’s equity by $4.1 million (€3.5 million)Further, the agreement also substantially reduces Evaxion’s overall liab ...

NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the second quarter of 2025 on Monday, August 4, 2025, before the opening of the U.S. financial markets. Axsome management will then host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update. To participate in the live ...

编者荐语： 这个月中规中矩 以下文章来源于AI产品榜 ，作者李榜主 AI产品榜 . AI产品榜 aicpb.com 按月发布AI产品榜单。AI产品榜大会，是你必参的会。 发起人：李榜主 wx：QBB2378 第 11 期 AI产品榜·应用榜(APP) （2025 年 06 月）由 AI产品榜、36kr、硅星人、 沃垠AI、小熊跑的快 联名发布。 AI产品榜 2025 年 06 月榜 本文里包含 9 个 AI 榜单，更多 AI产品榜单直接访问官网 AI产品榜 aicpb.com 。 | AI产品榜·应用榜（APP） | | | | --- | --- | --- | | 全球总榜 | MAU | 全球MAU增速榜 | | 国内总榜 | MAU | 国内MAU增速榜 | | 出海总榜 | MAU | 全球MAU降速榜 | | 全球下载榜 | | 国内下载榜 | | 订阅收入榜 | | | 引用数据标注来源：【公众号@ AI产品榜 aicpb.com 】 AI 发展到今天，我们想，要完全发挥 AI 的能力，不仅需要软件，还需要硬件，甚至需要一个新的计算终端设备。 所以，在AI产品榜发榜 2 周年之际：我们将举办 A ...

2025年，音乐行业正经历着一场前所未有的变革，而人工智能音乐人的崛起，就是其中一股最大的冲击潮。 从Aventhis到The Devil Inside，这些所谓的非真人AI音乐"艺术家"，正凭借AI的力量大规模涌入主流音乐流媒体平台，给传统音乐生态带来了巨大冲击， 敲响了行业危机的警钟。 本周，MBW对Aventhis的报道在音乐界掀起了轩然大波。大家都推测这不是真人艺术家，Aventhis的YouTube频道的匿名所有者也写道："声音和图像是在 人工智能的帮助下创建的。歌词是我写的。" 一股令人胆寒的趋势正在发生——人类创作者在音乐平台的"人气"竟然开始干不过机器音乐人了。 如今，每天有超过20000条完全由人工智能生成的轨迹充斥着Deezer的平台。4月份，机器人制作的音频占"上传内容总量"的18%。 02 这位乡村"艺术家"，由AI生成的曲目在Spotify上每月竟能吸引超100万听众，这一数据足以让众多传统音乐人瞠目结舌。 01 而Aventhis并非个例，另一支人工智能生成乐队The Devil Inside同样备受欢迎，在Spotify上每月也拥有近70万听众。 The Devil Inside ...

Core Points - HUTCHMED will announce its interim results for the six months ended June 30, 2025, on August 7, 2025, at 7:00 am EDT [1] - The company will host two webcast presentations for analysts and investors to discuss the interim results, with the English session at 8:00 am EDT and the Chinese session at 8:30 am HKT on August 8, 2025 [2] - Both webcasts will be available live on the company website, with a replay accessible shortly after the events [3] Company Overview - HUTCHMED is an innovative, commercial-stage biopharmaceutical company focused on the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases [4] - The company has successfully marketed its first three medicines in China, with the first also approved globally, including in the US, Europe, and Japan [4]

COPENHAGEN, Denmark, July 1, 2025 - Evaxion A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces several key executive management changes to optimize value from its proprietary AI-Immunology™ platform and pipeline. Christian Kanstrup has stepped down as Chief Executive Officer (CEO) and Evaxion has initiated the search for a new permanent CEO to lead its next phase of growth and to accelerate value creation from its AI-based t ...

OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the publication of its inaugural Letter to Shareholders. The Company’s CEO and Board of Directors wish to share with shareholders the key achievements of recent months, the foundations of its growth strategy and perspectives for the future. The Letter to Shareholders is available on the Company's website: https://tinyurl.com/2n3rhnpn. ABOU ...

Core Viewpoint - The rise of AI singer Yuri, created by AI.TALK, marks a significant moment in the AI music industry, with her debut music video "SURREAL" achieving over 7 million views across platforms, indicating a growing acceptance and interest in AI-generated music [1][7]. Group 1: AI Singer Development - The success of Yuri is attributed to advancements in music and video generation models, allowing for high-quality production that blurs the line between AI and human-generated content [7][12]. - Unlike previous virtual idols, Yuri represents a new wave of AI singers that can create music autonomously, leveraging AI models for both music composition and video production [6][8]. Group 2: Market Dynamics - The AI digital human market in China is projected to reach approximately 4.12 billion yuan in 2024, with a year-on-year growth of 85.3%, highlighting the rapid expansion of this sector [12]. - The commercial potential of AI singers is compared to traditional virtual idols, suggesting that AI singers can replicate successful monetization strategies such as merchandise, concerts, and collaborations [8][11]. Group 3: Challenges and Opportunities - Despite the potential, AI singers face challenges in achieving widespread recognition and maintaining audience engagement, as seen with other AI singers like Qiyue, which struggled to gain traction despite significant backing [10][11]. - The ability to create high-quality music and videos is essential for the commercial success of AI singers, as the market becomes increasingly competitive with more entrants expected [12][13].

After years of struggling with market share losses and uneven execution, Elanco Animal Health Incorporated ELAN appears to be turning a corner. What Happened: Investor meetings hosted by William Blair this week gave analysts enough confidence to upgrade the stock, citing a stabilized core business and promising momentum in its innovation pipeline. With new product launches in both livestock and pet health, Elanco is better positioned for growth—though it still faces stiff competition from larger rivals like ...

Key Takeaways Cisco Systems (CSCO) hit a 52-week high of $67.49 on Wednesday. The stock has rallied 14.7% year over year, indicating strong investor confidence in the company's rising prospects. Cisco's rally has been supported by solid earnings results, strong gross and operating margin expansion and an upbeat outlook for the coming quarter. This momentum also reflects the company's aggressive push into AI, a consistent rollout of innovative products and overall operational strength. Juniper is unique in i ...